12月15日，香港生物科技协会与浦发集团在香港签署战略合作框架协议。浦发集团党委副书记、总经理陆基出席，香港生物科技协会主席于常海、副主席梁传昕，香港立法会人大代表黄英豪、尚海龙，浦发·新原力合作伙伴瀚辰蓝西以及30多位香港生物科技界企业家受邀参加，浦发集团向现场来宾介绍了浦发集团产业投资合作优惠政策。
Events in 2023
Hong Kong, being the gateway to China, provides a rich source of opportunities for overseas investors looking to capitalize on the growth of the Greater Bay Area (GBA). Meanwhile, for companies from China, Hong Kong is a bridge to connect with the West. Moreover, the new listing rules adopted by the Hong Kong Stock Exchange (HKEX) which allow pre-revenue biotech companies to be listed on the HKEX is a bold imperative step for the growth of the biotech sector in Hong Kong. Thus, we could not think of a better way to kick-start the Asian biotech revolution than by organizing BIOHK2023 convention in Hong Kong, the potential biotech epicentre of Asia. This is a golden opportunity to personally view the major GBA cities involved in the future of biotechnology by becoming a part of this historical event.
